Matched control

DRUG3 trials

Sponsors

Pfizer, Syntara, Noom Inc.

Conditions

Behavior, HealthBronchiectasisObesityOptic Nerve DiseasesWeight Loss

Phase 3

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

TerminatedNCT00359632

PfizerOptic Nerve Diseases

Start: 2008-11-30End: 2013-12-31Updated: 2015-06-26

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

CompletedNCT00669331

SyntaraBronchiectasis

Start: 2009-11-30End: 2014-01-31Updated: 2016-04-29

Unknown Phase

Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention

CompletedNCT04522245

Noom Inc.Behavior, Health, Obesity, Weight Loss

Start: 2020-10-01End: 2021-07-15Updated: 2021-07-20

Related Papers

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial

Thorax2014-09-21167 citations